UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 61

Sortiert nach

Latent Membrane Protein 2A-Mediated Effects on the Phosphatidylinositol 3-Kinase/Akt Pathway

Journal of Virology, 2000-11, Vol.74 (22), p.10838-10845

2000

Volltextzugriff (PDF)

Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer

The New England journal of medicine, 2022-02, Vol.386 (6), p.556-567

2022

Volltextzugriff (PDF)

Pembrolizumab for Early Triple-Negative Breast Cancer

The New England journal of medicine, 2020-02, Vol.382 (9), p.810-821

2020

Volltextzugriff (PDF)

Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer

The New England journal of medicine, 2020-02, Vol.382 (7), p.610-621

2020

Volltextzugriff (PDF)

Tyrosine 112 of Latent Membrane Protein 2A Is Essential for Protein Tyrosine Kinase Loading and Regulation of Epstein-Barr Virus Latency

Journal of Virology, 1998-10, Vol.72 (10), p.7796-7806

1998

Volltextzugriff (PDF)

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

The lancet oncology, 2017-12, Vol.18 (12), p.1688-1700

2017

Volltextzugriff (PDF)

Abstract PS11-32: Mario-3 phase II study safety run-in evaluating a novel triplet combination of eganelisib (formerly IPI-549), atezolizumab (atezo), and nab-paclitaxel (nab-pac) as first-line (1L) therapy for locally advanced or metastatic triple-negative breast cancer (TNBC)

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS11-32-PS11-32

2021

Volltextzugriff (PDF)

Abstract P5-16-02: Updated efficacy, safety and translational data from MARIO-3, a phase II open-label study evaluating a novel triplet combination of eganelisib (IPI-549), atezolizumab (atezo), and nab-paclitaxel (nab-pac) as first-line (1L) therapy for locally advanced or metastatic triple-negative breast cancer (TNBC)

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P5-P5-16-02

2022

Volltextzugriff (PDF)

GLI Activates Transcription through a Herpes Simplex Viral Protein 16-Like Activation Domain

The Journal of biological chemistry, 1998-02, Vol.273 (6), p.3496-3501

1998

Volltextzugriff (PDF)

Novel receptor tyrosine kinase targeted combination therapies for imatinib-resistant gastrointestinal stromal tumors (GIST)

Oncotarget, 2015-02, Vol.6 (4), p.1954-1966

2015

Volltextzugriff (PDF)

Phase 1b study of safety, tolerability and efficacy of R1507, a monoclonal antibody to IGF-1R in combination with multiple standard oncology regimens in patients with advanced solid malignancies

Cancer chemotherapy and pharmacology, 2014-03, Vol.73 (3), p.467-473

2014

Volltextzugriff (PDF)

Phase Ib study of open-label AMG 386 plus paclitaxel (P) and trastuzumab (T) or capecitabine (C) and lapatinib (L) in patients (pts) with HER2+ locally recurrent or metastatic breast cancer (MBC)

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.529-529

2012

Volltextzugriff (PDF)

Phase Ib study of safety, tolerability, and efficacy of R1507 a monoclonal antibody to IGF-1R in combination with multiple standard chemotherapy regimens in patients with advanced solid malignancies

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.e13574-e13574

2013

Volltextzugriff (PDF)

Pentostatin and Alemtuzumab: An Immunosuppressive Nonmyeloablative Preparative Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT)

Blood, 2009-11, Vol.114 (22), p.4312-4312

2009

Volltextzugriff (PDF)

Tyrosines 60, 64, and 101 of Epstein–Barr Virus LMP2A Are Not Essential for Blocking B Cell Signal Transduction

Virology (New York, N.Y.), 1999-10, Vol.263 (2), p.485-495

1999

Volltextzugriff (PDF)

The Effects of the Epstein-Barr Virus Latent Membrane Protein 2a on B Cell Function

International reviews of immunology, 2001, Vol.20 (6), p.805-835

2001

Volltextzugriff (PDF)

Analysis of latent membrane protein 2A (LMP2A) in regulating B cell signaling

Swart, Rachel Elizabeth

2001

Volltextzugriff (PDF)

Measles skin rash: Infection of lymphoid and myeloid cells in the dermis precedes viral dissemination to the epidermis

PLoS pathogens, 2020-10, Vol.16 (10), p.e1008253-e1008253

2020

Volltextzugriff (PDF)

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2B6 and Efavirenz‐Containing Antiretroviral Therapy

Clinical pharmacology and therapeutics, 2019-10, Vol.106 (4), p.726-733

2019

Volltextzugriff (PDF)

Quantifying early marine diagenesis in shallow-water carbonate sediments

Geochimica et cosmochimica acta, 2018-09, Vol.236, p.140-159

2018

Volltextzugriff (PDF)

Mobile health adherence for the detection of recurrent recent-onset atrial fibrillation

Heart (British Cardiac Society), 2023-01, Vol.109 (1), p.26

2023

Volltextzugriff (PDF)

Air-Sea Fluxes With a Focus on Heat and Momentum

Frontiers in Marine Science, 2019-07, Vol.6

2019

Volltextzugriff (PDF)

Cardioversion strategy impacts rate control during recurrences in patients with paroxysmal atrial fibrillation: A subanalysis of the RACE 7 ACWAS trial

Clinical cardiology (Mahwah, N.J.), 2024-01, Vol.47 (1), p.e24161-n/a

2024

Volltextzugriff (PDF)

Development and internal validation of a model for postoperative morbidity in adults undergoing major elective colorectal surgery: the peri‐operative quality improvement programme (PQIP) colorectal risk model

Anaesthesia, 2022-12, Vol.77 (12), p.1356-1367

2022

Volltextzugriff (PDF)

1 – 25 von 61

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(56)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(36)
Life Sciences & Biomedicine
(28)
Humans
(22)
Female
(13)
Aged
(10)
Middle Aged
(10)
Patients
(9)
Surgery
(9)
Male
(8)
Adult
(7)
Aged, 80 And Over
(6)
Anesthesiology
(6)
Computer Science
(6)
General & Internal Medicine
(6)
Human-Centered Computing -- Human Computer Interaction
(6)
Technology
(6)
Animals
(5)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(5)
Medicine, General & Internal
(5)
Accessibility
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Latent Membrane Protein 2A-Mediated Effects on the Phosphatidylinositol 3-Kinase/Akt Pathway

Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer

Pembrolizumab for Early Triple-Negative Breast Cancer

Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer

Tyrosine 112 of Latent Membrane Protein 2A Is Essential for Protein Tyrosine Kinase Loading and Regulation of Epstein-Barr Virus Latency

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Abstract PS11-32: Mario-3 phase II study safety run-in evaluating a novel triplet combination of eganelisib (formerly IPI-549), atezolizumab (atezo), and nab-paclitaxel (nab-pac) as first-line (1L) therapy for locally advanced or metastatic triple-negative breast cancer (TNBC)

GLI Activates Transcription through a Herpes Simplex Viral Protein 16-Like Activation Domain

Novel receptor tyrosine kinase targeted combination therapies for imatinib-resistant gastrointestinal stromal tumors (GIST)

Phase 1b study of safety, tolerability and efficacy of R1507, a monoclonal antibody to IGF-1R in combination with multiple standard oncology regimens in patients with advanced solid malignancies

Phase Ib study of open-label AMG 386 plus paclitaxel (P) and trastuzumab (T) or capecitabine (C) and lapatinib (L) in patients (pts) with HER2+ locally recurrent or metastatic breast cancer (MBC)

Phase Ib study of safety, tolerability, and efficacy of R1507 a monoclonal antibody to IGF-1R in combination with multiple standard chemotherapy regimens in patients with advanced solid malignancies

Pentostatin and Alemtuzumab: An Immunosuppressive Nonmyeloablative Preparative Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT)

Tyrosines 60, 64, and 101 of Epstein–Barr Virus LMP2A Are Not Essential for Blocking B Cell Signal Transduction

The Effects of the Epstein-Barr Virus Latent Membrane Protein 2a on B Cell Function

Analysis of latent membrane protein 2A (LMP2A) in regulating B cell signaling

Measles skin rash: Infection of lymphoid and myeloid cells in the dermis precedes viral dissemination to the epidermis

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2B6 and Efavirenz‐Containing Antiretroviral Therapy

Quantifying early marine diagenesis in shallow-water carbonate sediments

Mobile health adherence for the detection of recurrent recent-onset atrial fibrillation

Air-Sea Fluxes With a Focus on Heat and Momentum

Cardioversion strategy impacts rate control during recurrences in patients with paroxysmal atrial fibrillation: A subanalysis of the RACE 7 ACWAS trial

Development and internal validation of a model for postoperative morbidity in adults undergoing major elective colorectal surgery: the peri‐operative quality improvement programme (PQIP) colorectal risk model

Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial

Suchergebnisse filtern